{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:20:02Z","timestamp":1793582402768,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    We investigated the effects of the maintenance of angiotensin-converting enzyme inhibitors (ACE inhibitors) the day of the surgery on the incidence of postoperative acute kidney injury (AKI) and cardiac events in patients undergoing cardiac surgery.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We performed a multicentric observational study with propensity matching on 1,072 patients treated with ACE inhibitors. We collected their baseline demographic data, comorbidities, and operative and postoperative outcomes. AKI was defined by KDIGO (Kidney Disease: Improving Global Outcome).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Maintenance of an ACE inhibitor was not associated with an increased risk of AKI (OR: 1.215 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.657\u20132.24),\n                    <jats:italic>p<\/jats:italic>\n                    = 0.843, 71 patients (25.1%) vs. 68 patients (24%)). Multivariate logistic regression and sensitive analysis did not demonstrate any association between ACE inhibitor maintenance and AKI, following cardiac surgery (OR: 1.03 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.81\u20131.3)). No statistically significant difference occurs in terms of incidence of cardiogenic shock (OR: 1.315 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.620\u20132.786)), stroke (OR: 3.313 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.356\u201327.523)), vasoplegia (OR: 0.741 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.419\u20131.319)), postoperative atrial fibrillation (OR: 1.710 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.936\u20133.122)), or mortality (OR: 2.989 (CI\n                    <jats:sub>95%<\/jats:sub>\n                    :0.343\u201326.034)). ICU and hospital length of stays did not differ (3 [2; 5] vs. 3 [2; 5] days,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.963 and 9.5 [8; 12] vs. 10 [8; 14] days,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.638).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Our study revealed that maintenance of ACE inhibitors on the day of the surgery was not associated with increased postoperative AKI. ACE inhibitor maintenance was also not associated with an increased rate of postoperative major cardiovascular events (arterial hypotension, cardiogenic shock, vasopressors use, stroke and death).\n                  <\/jats:p>","DOI":"10.3389\/fphar.2024.1343647","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:03:32Z","timestamp":1714651412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Pre-operative maintenance of angiotensin-converting enzyme inhibitors is not associated with acute kidney injury in cardiac surgery patients with cardio-pulmonary bypass: a propensity-matched multicentric analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Pierre","family":"Guilleminot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Abou-Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Besnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belaid","family":"Bouhemad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Gr\u00e9goire","family":"Guinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Collaborator study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.amjcard.2012.05.021","article-title":"Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting","volume":"110","author":"Bandeali","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.athoracsur.2008.06.018","article-title":"Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting","volume":"86","author":"Benedetto","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.jvca.2023.05.032","article-title":"Adult cardiac surgery-associated acute kidney injury: joint consensus report","volume":"37","author":"Brown","year":"2023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"B3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1053\/j.jvca.2021.10.009","article-title":"Inconsistent methodology as a barrier to meaningful research outputs from studies of atrial fibrillation after cardiac surgery","volume":"36","author":"Campbell","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000505896","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers after acute kidney injury: friend, foe, or acquaintance?","volume":"51","author":"Coca","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1681\/ASN.2013070742","article-title":"Urinary biomarkers of AKI and mortality 3 years after cardiac surgery","volume":"25","author":"Coca","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3109\/0886022X.2013.777891","article-title":"Is administration of preoperative angiotensin-converting enzyme inhibitors important for renal protection after cardiac surgery?","volume":"35","author":"Dag","year":"2013","journal-title":"Ren. Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.hlc.2020.06.003","article-title":"Effects of preoperative angiotensin-converting enzyme inhibitor therapy on postoperative renal function in cardiac surgery","volume":"29","author":"De Bono","year":"2020","journal-title":"Heart Lung Circ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.111.059527","article-title":"Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality","volume":"126","author":"Drenger","year":"2012","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1213\/ANE.0000000000006383","article-title":"Balanced nonopioid general anesthesia with lidocaine is associated with lower postoperative complications compared with balanced opioid general anesthesia with sufentanil for cardiac surgery with cardiopulmonary bypass: a propensity matched cohort study","volume":"136","author":"Guinot","year":"","journal-title":"Anesth. Analg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101200","DOI":"10.1016\/j.accpm.2023.101200","article-title":"Epidemiology, risk factors and outcomes of norepinephrine use in cardiac surgery with cardiopulmonary bypass: a multicentric prospective study","volume":"42","author":"Guinot","year":"","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12871-019-0802-y","article-title":"Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study","volume":"19","author":"Guinot","year":"2019","journal-title":"BMC Anesthesiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1213\/ANE.0000000000002837","article-title":"A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery","volume":"127","author":"Hollmann","year":"2018","journal-title":"Anesth. Analg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2044.1994.tb14234.x","article-title":"The renin-angiotensin system and angiotensin converting enzyme (ACE) inhibitors","volume":"49","author":"Kellow","year":"1994","journal-title":"Anaesthesia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit. Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.accpm.2022.101059","article-title":"Guidelines on enhanced recovery after cardiac surgery under cardiopulmonary bypass or off-pump","volume":"41","author":"Mertes","year":"2022","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jacc.2009.07.008","article-title":"Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting","volume":"54","author":"Miceli","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5005\/jp-journals-10071-23427","article-title":"Effect of goal-directed hemodynamic therapy in postcardiac surgery patients","volume":"24","author":"Patel","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1213\/ANE.0000000000006068","article-title":"Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery","volume":"135","author":"Peng","year":"2022","journal-title":"Anesth. Analg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.mayocp.2022.03.039","article-title":"Preoperative management of cardiovascular medications: a society for perioperative assessment and quality improvement (spaqi) consensus statement","volume":"97","author":"Sahai","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS Guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1053\/j.jvca.2020.03.025","article-title":"Con: does preoperative discontinuation of angiotensin-converting enzyme inhibitors\/angiotensin II receptor blockers reduce postoperative acute kidney injury?","volume":"34","author":"Tempe","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e009917","DOI":"10.1161\/JAHA.118.009917","article-title":"Comparison of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker management strategies before cardiac surgery: a pilot randomized controlled registry trial","volume":"7","author":"van Diepen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1053\/j.ajkd.2013.04.018","article-title":"Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies","volume":"62","author":"Yacoub","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/ejcts\/ezu298","article-title":"Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery","volume":"47","author":"Zhang","year":"2015","journal-title":"Eur. J. Cardiothorac. Surg."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1343647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:03:36Z","timestamp":1714651416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1343647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":29,"alternative-id":["10.3389\/fphar.2024.1343647"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1343647","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"1343647"}}